Antiplatelet Therapy Combinations and Thrombogenicity in Patients with Non-Valvular Atrial Fibrillation

BACKGROUND AND OBJECTIVES: Combination antiplatelet therapy reduces the risk of ischemic stroke compared with aspirin monotherapy in non-valvular atrial fibrillation (NVAF) patients. The underlying mechanism, however, remains unclear. In addition, the association between platelet inhibition and thro...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Yongwhi, Kim, Kye Hwan, Kang, Min Gyu, Ahn, Jong-Hwa, Jang, Jeong Yoon, Park, Hyun Woong, Koh, Jin-Sin, Park, Jeong-Rang, Hwang, Seok-Jae, Jeong, Young-Hoon, Hwang, Jin-Yong, Lee, Hye Ryun, Kwak, Choong Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Cardiology 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449531/
https://www.ncbi.nlm.nih.gov/pubmed/28567087
http://dx.doi.org/10.4070/kcj.2016.0384

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449531/
https://www.ncbi.nlm.nih.gov/pubmed/28567087
http://dx.doi.org/10.4070/kcj.2016.0384

Ejemplares similares